Another year, and another update on Orqis’ Cancion system for congestive heart failure. This innovative device was first covered by us in ’05, and we updated you last year. Now it seems patients are finally being enrolled in this novel medical device trial:
The Cancion System, manufactured by Orqis Medical Corp., is a pump device that is introduced into the body via catheters inserted through tiny incisions in the groin. Once placed, the pump draws blood from the patient’s iliac artery – located in the pelvis – into a small external pump. From there, the blood goes through another catheter placed in the heart’s descending aorta, where it is re-introduced for continuous blood flow.
“The device itself takes only 20 to 25 minutes to insert, and we use local anesthesia,” said Dr. Addo, an interventional cardiologist. “The use of this may help patients avoid or delay much more invasive therapy.”
Patients receive the pump in the hospital, and the device is removed after treatment, said Dr. Addo. Effects of treatment can last several weeks or months.
…The pump could function as a stopgap to help some patients maintain their own heart function for a period of time, which in turn might minimize hospitalizations.
The name of the trial is ironic: MOMENTUM — for Multicenter trial of the Orqis MEdical CRS for the eNhanced Treatment of CHF, Unresponsive to Medical therapy. It’s hard to glean ‘momentum’ from that title, or, for that matter, this project. But it sounds promising…
More from Orqis Corp’s product page…